Soluble interleukin-2 (IL-2) receptor expression in patients with myelodysplastic syndromes is induced by granulocyte-macrophage colony-stimulating factor and IL-3.
Zwierzina
H
H
Herold
M
M
Geissler
D
D
Schöllenberger
S
S
Schmalzl
F
F
D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology*; D006801:Humans; D007377:Interleukin-3 / Q000494:pharmacology*; D009190:Myelodysplastic Syndromes / Q000097:blood*; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis*
D007377:Interleukin-3; D015375:Receptors, Interleukin-2; D016178:Granulocyte-Macrophage Colony-Stimulating Factor